Trademark: 97462441
Word
TETRIDAR
Status
Pending
Status Code
730
Status Date
Tuesday, October 31, 2023
Serial Number
97462441
Mark Type
4000
Filing Date
Thursday, June 16, 2022
Published for Opposition
Tuesday, March 7, 2023

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events
Nov 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 31, 2023
Sou Extension 1 Granted
Oct 31, 2023
Sou Extension 1 Filed
Oct 31, 2023
Sou Teas Extension Received
May 2, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2023
Published For Opposition
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Jan 27, 2023
Approved For Pub - Principal Register
Jan 27, 2023
Examiner's Amendment Entered
Jan 27, 2023
Notification Of Examiners Amendment E-Mailed
Jan 27, 2023
Examiners Amendment E-Mailed
Jan 27, 2023
Examiners Amendment -Written
Jan 25, 2023
Assigned To Examiner
Jul 1, 2022
New Application Office Supplied Data Entered
Jun 20, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24